On Monday, Pfizer issued a voluntary recall of its blood pressure drug Accuretic along with two of its generic hypertension treatments distributed by Greenstone in the United States because of the presence of cancer-causing agents. Earlier in the month, they recalled two of its blood pressure medicines in Canada.
Click here to read the entire article.